Jonathan Heddle, Ph.D., D.Sc.
Chief Scientific Officer
Jonathan Heddle, Ph.D., DSc., is the founder and Chief Scientific Officer at nCage Therapeutics, and leads the company’s research and development activities focused on design of novel protein structures and therapeutics. Jonathan also serves as an Extraordinary Professor at the Malopolska Centre of Biotechnology (MCB), at Jagiellonian University in Krakow. Jonathan has >20 years of experience in researching natural and artificial bionanomachines. He has made significant contributions to the understanding of DNA gyrase an important antibacterial target, and has played a major role in designing novel artificial structures from DNA and proteins including nanorobotic DNA boxes, protein nanotubes and protein cages.
Prior to nCage and MCB, Jonathan carried out research at the John Innes Centre, UK and spent over a decade in Japan where he was engaged in academic teaching and investigational research, and responsible for laboratories at Tokyo Institute of Technology, and RIKEN, Japan’s largest scientific research institution.
Jonathan received his DSc. from the Institute of Biochemistry and Biophysics, Polish Academy of Sciences, his Ph.D. in Biochemistry from the University of Leicester, and a B.Pharma (Hons) from the University of Nottingham, United Kingdom.